Neurosurgical grade biomaterial, DuraGen
TM
, offers a promising matrix for protected delivery of neural stem cells in clinical cell therapies
Future Healthc J
.
2019 Mar;6(Suppl 1):76.
doi: 10.7861/futurehosp.6-1-s76.
Authors
Louise Finch
1
,
Christopher Adams
2
,
Jon Sen
1
3
,
Jacqueline Tickle
1
,
Nikolaos Tzerakis
4
,
Divya Maitreyi Chari
1
Affiliations
1
Institute for Science and Technology in Medicine, Keele University, Stoke-on-Trent, UK.
2
Faculty of Natural Sciences, Keele University, Stoke-on-Trent, UK.
3
Neurosurgery department, HCA Healthcare, London, UK.
4
Neurosurgery department, University Hospitals of North Midlands, Stoke-on-Trent, UK.
PMID:
31363597
PMCID:
PMC6616718
DOI:
10.7861/futurehosp.6-1-s76
No abstract available
Grants and funding
MC_PC_16049/MRC_/Medical Research Council/United Kingdom